SCHEMBL7654167

SCHEMBL7654167

Oc1nc2cc(-c3nc4cc(-c5nc6cc(-c7ccccc7)ccc6[nH]5)ccc4[nH]3)ccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.51
RAB9A P51151 7/20 0.51
GAA P10253 2/20 0.51
KDM4E B2RXH2 7/20 0.49
ALDH1A1 P00352 7/20 0.49
HPGD P15428 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
CHEK2 O96017 1/20 0.47
PTPN1 P18031 1/20 0.47
TP53 P04637 2/20 0.47
HSD17B10 Q99714 2/20 0.47
DGAT1 O75907 1/20 0.46
KCNH2 Q12809 1/20 0.46
PRMT1 Q99873 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22649095 0.87 NPC1 (0.67) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL27825168 0.83 PRMT1 (0.54) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL57009 0.82 POLB (0.57) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7658170 0.82 MMP13 (0.49) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL7659118 0.82 ALDH1A1 (0.54) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL28793724 0.82 PRMT1 (0.52) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7656217 0.82 NPC1 (0.51) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7660194 0.81 NPC1 (0.47) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7652952 0.81 SMN1; SMN2 (0.56) NPC1RAB9AGAAKDM4EALDH1A1
SCHEMBL7653231 0.81 SMN1; SMN2 (0.56) NPC1RAB9AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399642-B2 TRIS BENZIMIDAZOLES; FUNGICIDES, ANTICARCINOGENIC AGENTS, ENZYME INHIBITOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-06-04 US disclosed
US-20010009919-A1 Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-07-26 US disclosed
US-6221892-B1 Heterocyclic topoisomerase poisons THE STATE OF UNIVERSITY OF NEW JERSEY, RUTGERS 2001-04-24 US disclosed
EP-1054870-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-11-29 EP disclosed
US-6063801-A Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-05-16 US disclosed
WO-1999041241-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010009919-A1 Heterocyclic topoisomerase poisons TOP1, TOP2A, TOP2B NPC1 2875/4885RAB9A 2315/4885GAA 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.